These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36286520)

  • 21. Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh.
    Chowdhury F; Begum YA; Alam MM; Khan AI; Ahmed T; Bhuiyan MS; Harris JB; LaRocque RC; Faruque AS; Endtz H; Ryan ET; Cravioto A; Svennerholm AM; Calderwood SB; Qadri F
    Infect Immun; 2010 May; 78(5):2117-24. PubMed ID: 20176796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Vibrio cholerae O1 and O139 in environmental waters of rural Bangladesh: a flow-cytometry-based field trial.
    Righetto L; Zaman RU; Mahmud ZH; Bertuzzo E; Mari L; Casagrandi R; Gatto M; Islam S; Rinaldo A
    Epidemiol Infect; 2015 Aug; 143(11):2330-42. PubMed ID: 25496520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal immunologic responses in cholera patients in Bangladesh.
    Uddin T; Harris JB; Bhuiyan TR; Shirin T; Uddin MI; Khan AI; Chowdhury F; LaRocque RC; Alam NH; Ryan ET; Calderwood SB; Qadri F
    Clin Vaccine Immunol; 2011 Mar; 18(3):506-12. PubMed ID: 21248157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
    Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Bhuiyan TR; Ivers LC; Ternier R; Jerome JG; Pfister HB; Lu X; Soliman SE; Ruttens B; Saksena R; Mečárová J; Čížová A; Qadri F; Bystrický S; Kováč P; Xu P; Ryan ET
    mSphere; 2021 Aug; 6(4):e0011421. PubMed ID: 34232076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.
    Uddin T; Aktar A; Xu P; Johnson RA; Rahman MA; Leung DT; Afrin S; Akter A; Alam MM; Rahman A; Chowdhury F; Khan AI; Bhuiyan TR; Bufano MK; Rashu R; Yu Y; Wu-Freeman Y; Harris JB; LaRocque RC; Charles RC; Kováč P; Calderwood SB; Ryan ET; Qadri F
    Am J Trop Med Hyg; 2014 May; 90(5):873-81. PubMed ID: 24686738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
    Adekunle O; Dretler A; Kauffman RC; Cho A; Rouphael N; Wrammert J
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009743. PubMed ID: 34478460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1.
    Jayasekera CR; Harris JB; Bhuiyan S; Chowdhury F; Khan AI; Faruque AS; Larocque RC; Ryan ET; Ahmed R; Qadri F; Calderwood SB
    J Infect Dis; 2008 Oct; 198(7):1055-61. PubMed ID: 18729782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.
    Patel SM; Rahman MA; Mohasin M; Riyadh MA; Leung DT; Alam MM; Chowdhury F; Khan AI; Weil AA; Aktar A; Nazim M; LaRocque RC; Ryan ET; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2012 Jun; 19(6):842-8. PubMed ID: 22518009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative genomics of Vibrio cholerae O1 isolated from cholera patients in Bangladesh.
    Hossain ZZ; Leekitcharoenphon P; Dalsgaard A; Sultana R; Begum A; Jensen PKM; Hendriksen RS
    Lett Appl Microbiol; 2018 Oct; 67(4):329-336. PubMed ID: 29981154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
    Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
    Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic limitations to accurate diagnosis of cholera.
    Alam M; Hasan NA; Sultana M; Nair GB; Sadique A; Faruque AS; Endtz HP; Sack RB; Huq A; Colwell RR; Izumiya H; Morita M; Watanabe H; Cravioto A
    J Clin Microbiol; 2010 Nov; 48(11):3918-22. PubMed ID: 20739485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.
    Chowdhury F; Akter A; Bhuiyan TR; Biswas R; Firoj MG; Tauheed I; Harris JB; Larocque RC; Ross AG; McMillan NAJ; Charles RC; Ryan ET; Calderwood SB; Qadri F
    Front Immunol; 2022; 13():1067737. PubMed ID: 36618409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.
    Qadri F; Wennerås C; Albert MJ; Hossain J; Mannoor K; Begum YA; Mohi G; Salam MA; Sack RB; Svennerholm AM
    Infect Immun; 1997 Sep; 65(9):3571-6. PubMed ID: 9284121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
    Leung DT; Rahman MA; Mohasin M; Patel SM; Aktar A; Khanam F; Uddin T; Riyadh MA; Saha A; Alam MM; Chowdhury F; Khan AI; Charles R; LaRocque R; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2012 May; 19(5):690-8. PubMed ID: 22441386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-Based Serologic Survey of Vibrio cholerae Antibody Titers before Cholera Outbreak, Haiti, 2022.
    Clutter CH; Klarman MB; Cajusma Y; Cato ET; Abu Sayeed M; Brinkley L; Jensen O; Baril C; De Rochars VMB; Azman AS; Long MT; Cummings D; Leung DT; Nelson EJ
    Emerg Infect Dis; 2023 Sep; 29(9):1864-1867. PubMed ID: 37487168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
    Mayo-Smith LM; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Calderwood SB; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.
    Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F
    Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh.
    Rahman A; Rashu R; Bhuiyan TR; Chowdhury F; Khan AI; Islam K; LaRocque RC; Ryan ET; Wrammert J; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2013 Oct; 20(10):1592-8. PubMed ID: 23945156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.